The Asia Pacific In-vitro Fertilization Microscopes Market would witness market growth of 11.9% CAGR during the forecast period (2022-2028).
One of the most prevalent hormonal illnesses among women of reproductive age is a polycystic ovarian syndrome (PCOS). Women who come with infertility often have been diagnosed with PCOS. The three significant signs of polycystic ovarian syndrome are polycystic ovaries, excessive body or facial hair, and irregular menstrual periods. Increased PCOS prevalence in women may cause infertility, increasing the need for in-vitro fertilization to have children. A severe clinical issue is the rising incidence of infertility. Such causes as aberrant morphology reduced sperm concentration, and poor sperm motility might all be contributing factors.
Hence, rising rates of male infertility and more knowledge of it have led to increased use of medications, hormone treatment, and ART. Among the leading causes of male infertility include alcohol use, smoking, obesity, stress, and alterations in lifestyle. Governments of various nations have made steps to enhance how infertility-related therapies are reimbursed in the respective countries. Also, it is anticipated that patients would choose in-vitro fertilization more due to increased patient data security by regulatory standards defined by regulatory bodies.
The "low fertility trap," in which having fewer children results in lower expenditure on education and related services, is causing governments in the region's wealthier nations to increase anxiety. This situation makes it increasingly harder to increase birth rates. The drop in fertility rate brought on by changes in living habits and the tendency towards postponed pregnancies has increased the need for IVF procedures across China. Also, in the following years, the market for in-vitro fertilization microscopes will expand significantly in the Asia Pacific region due to the cheap cost of IVF therapy.
The China market dominated the Asia Pacific In-vitro Fertilization Microscopes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $15,865.3 Thousands by 2028. The Japan market is estimated to grow a CAGR of 11.2% during (2022 - 2028). Additionally, The India market would display a CAGR of 12.6% during (2022 - 2028).
Based on End User, the market is segmented into Clinical and Academic Research. Based on Type, the market is segmented into Embryo Microscope, Upright Microscopes, Stereo Microscopes and Inverted Microscopes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide In-vitro Fertilization Microscopes Market is Projected to reach USD 202.2 Billion by 2028, at a CAGR of 11.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hamilton Thorne, Inc. (Hamilton Thorne, Ltd.), Olympus Corporation, Leica Microsystems GmbH (Danaher Corporation), Carl Zeiss AG, Nikon Corporation, Linkam Scientific Instruments, Meiji Techno Co., Ltd., Euromex Microscopen B.V. (Euromex Optics Group B.V.), Labomed Europe B.V., and Narishige Group.
By End User
By Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
